We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SOTK:NASDAQSono-Tek Corporation Analysis

Data as of 2026-06-26 - not real-time

$5.32

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Sono‑Tek’s stock is trading at $5.32, comfortably above its 20‑day SMA of 5.22 and its 50‑day SMA of 4.98, indicating a short‑term bullish bias, while the 200‑day SMA sits at 4.35, reinforcing a longer‑term uptrend. RSI sits at 54.5, suggesting neutral momentum, but the MACD histogram is negative (-0.019) and the MACD signal is bearish, hinting at possible near‑term weakness. Volume is decreasing and 30‑day volatility is high at 61%, which could amplify price swings. The beta of 0.69 points to lower systematic risk, yet the high fear‑and‑greed index (88.55, “Extreme Greed”) reflects strong market optimism.
Fundamentally, revenue grew 9.5% YoY to $20.9 M with healthy gross margins (~50%) and operating margins (~10.7%). The company holds $14.8 M in cash, carries no debt, and generates solid free cash flow (> $2 M). However, the current price implies a P/E of 48× versus the industry average of 36×, and the DCF fair value of $3.54 suggests the stock is significantly overvalued, with an implied upside/downside of roughly 41% against intrinsic value. The recent fiscal Q4/2026 earnings release underscores the growth trajectory but does not alleviate valuation concerns.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price above short‑term SMAs indicates bullish bias
  • Bearish MACD histogram and decreasing volume raise caution
  • Support at $4.70 and resistance at $5.74 define a narrow trading range

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Revenue growth of 9.5% with strong gross and operating margins
  • Robust cash position and zero debt provide financial flexibility
  • Market optimism reflected in extreme greed index supports demand

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Significant valuation gap between market price and DCF fair value
  • High P/E relative to industry peers suggests limited upside
  • Exposure to global markets introduces moderate geographic risk

Key Metrics & Analysis

Financial Health

Revenue Growth9.50%
Profit Margin8.64%
P/E Ratio48.4
ROE9.61%
ROA4.58%
P/B Ratio4.4
Op. Cash Flow$3.2M
Free Cash Flow$2.0M
Industry P/E36.1

Technical Analysis

TrendBullish
RSI54.5
Support$4.70
Resistance$5.74
MA 20$5.22
MA 50$4.98
MA 200$4.35
MACDBearish
VolumeDecreasing
Fear & Greed Index88.55

Valuation

Fair Value$3.54
Target Price$7.50
Upside/Downside40.98%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.69
Volatility61.25%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.